• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从记忆 T 细胞中无需合成肽段即可鉴定病毒表位和反应性 T 细胞受体。

Identification of virus epitopes and reactive T-cell receptors from memory T cells without peptide synthesis.

机构信息

Department of Basic Medical Science, School of Medicine, Tsinghua University, 100084, Beijing, China.

Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, 100084, Beijing, China.

出版信息

Commun Biol. 2024 Nov 4;7(1):1432. doi: 10.1038/s42003-024-07048-x.

DOI:10.1038/s42003-024-07048-x
PMID:39496850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11535475/
Abstract

Identifying epitopes and their corresponding T-cell receptor (TCR) sequences is crucial in the face of rapidly mutating viruses. Peptide synthesis is often required to confirm the exact epitope sequences, which is time-consuming and expensive. In this study, we introduce a scalable workflow to identify the exact sequences of virus epitopes and reactive TCRs targeting the epitopes from memory T cells. Following the narrowing down of epitopes to specific regions via the tandem minigene (TMG) system, our workflow incorporates the utilization of peptide-major histocompatibility complex-displaying yeasts (pMHC-displaying yeasts) to rapidly screen immunogenic epitopes' precise sequences, obviating the necessity for the chemical synthesis of peptides. Focusing on SARS-CoV-2, we identify the precise sequences of reactive TCRs, targeting conserved epitopes across the Coronaviridae family, from the blood of COVID-19-recovered individuals over 8 months. Notably, we reveal that at least 75% (6/8) of the tested donors harbor T cells targeting a shared epitope, KTFPPTEPK, derived from the N protein. Furthermore, several identified TCRs exhibit cross-reactivity to mutant epitopes, suggesting a potential mechanism for sustained T-cell responses against emerging SARS-CoV-2 variants.

摘要

在面对快速变异的病毒时,鉴定表位及其相应的 T 细胞受体(TCR)序列至关重要。通常需要进行肽合成来确认确切的表位序列,这既耗时又昂贵。在这项研究中,我们引入了一种可扩展的工作流程,用于从记忆 T 细胞中鉴定针对表位的病毒表位和反应性 TCR 的精确序列。在通过串联小基因(TMG)系统将表位缩小到特定区域后,我们的工作流程包括利用肽-主要组织相容性复合物展示酵母(pMHC 展示酵母)来快速筛选免疫原性表位的精确序列,从而避免了肽的化学合成的必要性。本研究聚焦于 SARS-CoV-2,我们从 COVID-19 康复者的血液中,在 8 个月的时间内鉴定出了针对冠状病毒科保守表位的反应性 TCR 的精确序列。值得注意的是,我们发现至少 75%(6/8)的测试供体具有靶向 N 蛋白衍生的共有表位 KTFPPTEPK 的 T 细胞。此外,一些鉴定出的 TCR 表现出对突变表位的交叉反应性,这表明针对不断出现的 SARS-CoV-2 变体持续 T 细胞反应的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c4b/11535475/7183c33a8062/42003_2024_7048_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c4b/11535475/2f187af02bf6/42003_2024_7048_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c4b/11535475/3301aba470f2/42003_2024_7048_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c4b/11535475/22e1638cb501/42003_2024_7048_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c4b/11535475/b1487249a33d/42003_2024_7048_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c4b/11535475/7183c33a8062/42003_2024_7048_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c4b/11535475/2f187af02bf6/42003_2024_7048_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c4b/11535475/3301aba470f2/42003_2024_7048_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c4b/11535475/22e1638cb501/42003_2024_7048_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c4b/11535475/b1487249a33d/42003_2024_7048_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c4b/11535475/7183c33a8062/42003_2024_7048_Fig5_HTML.jpg

相似文献

1
Identification of virus epitopes and reactive T-cell receptors from memory T cells without peptide synthesis.从记忆 T 细胞中无需合成肽段即可鉴定病毒表位和反应性 T 细胞受体。
Commun Biol. 2024 Nov 4;7(1):1432. doi: 10.1038/s42003-024-07048-x.
2
T-Cell Receptors Cross-Reactive to Coronaviral Epitopes Homologous to the SPR Peptide.T 细胞受体与冠状病毒表位交叉反应,这些表位与 SPR 肽同源。
Biochemistry (Mosc). 2024 Sep;89(9):1631-1642. doi: 10.1134/S0006297924090098.
3
Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs.基于质谱的 SARS-CoV-2 免疫原性表位及其 TCR 鉴定。
Proc Natl Acad Sci U S A. 2021 Nov 16;118(46). doi: 10.1073/pnas.2111815118.
4
Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.公共和私人 T 细胞受体识别的 HLA-A2 限制性 SARS-CoV-2 刺突表位的结构评估。
Nat Commun. 2022 Jan 10;13(1):19. doi: 10.1038/s41467-021-27669-8.
5
Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.SARS-CoV-2 的免疫原性 T 细胞表位可被未暴露个体的循环记忆和幼稚 CD8 T 细胞识别。
EBioMedicine. 2021 Oct;72:103610. doi: 10.1016/j.ebiom.2021.103610. Epub 2021 Oct 6.
6
SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.在 COVID-19 康复者中鉴定出的 SARS-CoV-2 特异性记忆 T 细胞表位。
Virus Res. 2021 Oct 15;304:198508. doi: 10.1016/j.virusres.2021.198508. Epub 2021 Jul 27.
7
Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents.非保守表位主导 COVID-19 恢复期患者的反向预先存在 T 细胞免疫。
Signal Transduct Target Ther. 2024 Jun 12;9(1):160. doi: 10.1038/s41392-024-01876-3.
8
Limited Recognition of Highly Conserved Regions of SARS-CoV-2.有限识别 SARS-CoV-2 的高度保守区域。
Microbiol Spectr. 2022 Feb 23;10(1):e0278021. doi: 10.1128/spectrum.02780-21.
9
CD8 T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses.针对 SARS-CoV-2 核衣壳表位的免疫优势 CD8 T 细胞与选择性季节性冠状病毒发生交叉反应。
Immunity. 2021 May 11;54(5):1055-1065.e5. doi: 10.1016/j.immuni.2021.04.006. Epub 2021 Apr 13.
10
SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 T cell activation in COVID-19 patients.SARS-CoV-2 全基因组 T 细胞表位图谱分析揭示了 COVID-19 患者中的免疫优势和大量 CD8+T 细胞激活。
Sci Immunol. 2021 Apr 14;6(58). doi: 10.1126/sciimmunol.abf7550.

本文引用的文献

1
SARS-CoV-2 infection establishes a stable and age-independent CD8 T cell response against a dominant nucleocapsid epitope using restricted T cell receptors.SARS-CoV-2 感染利用受限的 T 细胞受体建立了针对主要核衣壳表位的稳定且与年龄无关的 CD8 T 细胞应答。
Nat Commun. 2023 Oct 23;14(1):6725. doi: 10.1038/s41467-023-42430-z.
2
Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy.工程化用于细胞治疗的免疫抑制药物抗性装甲(IDRA)严重急性呼吸综合征冠状病毒2(SARS-CoV-2)T细胞。
Cell Mol Immunol. 2023 Nov;20(11):1300-1312. doi: 10.1038/s41423-023-01080-3. Epub 2023 Sep 5.
3
Neoantigens: promising targets for cancer therapy.
肿瘤新抗原:癌症治疗的有前途的靶点。
Signal Transduct Target Ther. 2023 Jan 6;8(1):9. doi: 10.1038/s41392-022-01270-x.
4
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia.用于分离和鉴定 SARS-CoV-2 变体的平台可快速鉴定澳大利亚的奥密克戎。
Nat Microbiol. 2022 Jun;7(6):896-908. doi: 10.1038/s41564-022-01135-7. Epub 2022 May 30.
5
SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection.SARS-CoV2 野生型和突变型特异性体液和 T 细胞免疫在接种疫苗后优于自然感染后。
PLoS One. 2022 Apr 25;17(4):e0266701. doi: 10.1371/journal.pone.0266701. eCollection 2022.
6
SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8 T cells.SARS-CoV-2 抗原暴露史塑造记忆 CD8 T 细胞的表型和特异性。
Nat Immunol. 2022 May;23(5):781-790. doi: 10.1038/s41590-022-01184-4. Epub 2022 Apr 5.
7
Rapid screening of TCR-pMHC interactions by the YAMTAD system.利用YAMTAD系统快速筛选TCR-pMHC相互作用
Cell Discov. 2022 Apr 5;8(1):30. doi: 10.1038/s41421-022-00386-2.
8
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron.SARS-CoV-2 疫苗接种可诱导能够交叉识别 Alpha 到奥密克戎变体的免疫 T 细胞记忆。
Cell. 2022 Mar 3;185(5):847-859.e11. doi: 10.1016/j.cell.2022.01.015. Epub 2022 Jan 24.
9
SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron.预计由 COVID-19 疫苗或感染引起的 SARS-CoV-2 细胞免疫反应对奥密克戎仍保持强大。
Viruses. 2022 Jan 2;14(1):79. doi: 10.3390/v14010079.
10
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies.一种传染性 SARS-CoV-2 B.1.1.529 奥密克戎病毒能够逃避治疗性单克隆抗体的中和作用。
Nat Med. 2022 Mar;28(3):490-495. doi: 10.1038/s41591-021-01678-y. Epub 2022 Jan 19.